How Reduced Smoking Saved Millions from Lung Cancer
Episode Overview
Over 3.8 million lung cancer deaths were averted due to reduced smoking from 1970 to 2022. Women gained more years per death averted compared to men. Smoking cessation medications during pregnancy did not increase risk of major congenital malformations. Obesity is linked to progressive brain structural changes. Remote interventions for substance use disorders show promise in reducing relapse rates.
The authors estimated 3.8 million lung cancer deaths were averted and 76 million PYL were gained during the study period
This episode of 'This Week in Addiction Medicine' dives into the significant decline in lung cancer deaths due to reduced cigarette smoking in the US from 1970 to 2022. The discussion highlights the immense impact of tobacco control measures, estimating that over 3.8 million lung cancer deaths were prevented, resulting in a gain of 76 million person-years of life.
The episode also explores the gender differences in these statistics, noting that while more deaths were averted in men, women gained more years per death averted. This underscores the importance of continued efforts in tobacco cessation programs. Additionally, the podcast covers several other fascinating studies. One examines the safety of smoking cessation medications during pregnancy, reassuringly finding no increased risk of major congenital malformations. Another study links obesity to progressive brain structural changes, providing insights for clinical interventions.
The effectiveness of remote interventions for substance use disorders is also scrutinised, revealing promising results for reducing relapse rates. Lastly, the episode touches on the potential risks associated with trazodone for insomnia in individuals with alcohol use disorder, suggesting safer alternatives. With its blend of cutting-edge research and practical advice, this episode offers valuable insights for anyone interested in addiction medicine.